Agios Pharmaceuticals
AGIO
AGIO
161 hedge funds and large institutions have $1.63B invested in Agios Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 49 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 163 → 161 (-2)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
18% less capital invested
Capital invested by funds: $1.99B → $1.63B (-$364M)
Holders
161
Holding in Top 10
6
Calls
$39M
Puts
$13.1M
Top Buyers
| 1 | +$53.9M | |
| 2 | +$14.6M | |
| 3 | +$7.34M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$7.21M |
| 5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$6.68M |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$10.9M | |
| 3 | -$9.83M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$7.92M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$7.65M |